QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Millot, G. A. Articles by Svinarchuk, F. Search for Related Content PubMed PubMed Citation Articles by Millot, G. A. Articles by Svinarchuk, F.

Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells

INSERM U362, Laboratoire Hématopoïèse et Cellules Souches, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France

^* Author for correspondence (e-mail: millot{at}ijm.jussieu.fr )

Accepted 11 March 2002

Thrombopoietin (TPO) plays a critical role in megakaryopoiesis through binding to its receptor Mpl. This involves activation of various intracellular signaling pathways, including phosphoinositide 3-kinase (PI3K) and the mitogen-activated protein kinase (MAPK) pathways. Their precise role in TPO-mediated proliferation, survival and differentiation is not fully understood. In the present study, we show that TPO induces different biological responses in Mpl-transduced BaF-3 cells, depending on the cell surface density of Mpl and the resulting activation level of signaling pathways. TPO mediates cell proliferation in cells expressing high levels of Mpl but only mediates survival without proliferation in cells expressing low levels of the receptor. By using the kinase inhibitors PD98059 and LY294002, we further showed that the activation level of the PI3K and MAPK p42/44 pathways is a determining factor for the proliferative effect. In cells expressing low levels of Mpl, the survival effect was strongly dependent on the activation level of the PI3K/AKT, but not the MAPK p42/44 pathway. Moreover, this effect was correlated with the phosphorylation level of BAD but not with the expression level of Bcl-X_L. However, PI3K pathway inhibition did not increase apoptosis when BaF-3 cells proliferated in response to TPO, indicating a compensating mechanism from other Mpl signaling pathways in this case.

Key words: Mpl, Threshold activation level, Proliferation, Survival, Signaling pathways

This article has been cited by other articles:

				C. Simon, E. Dondi, A. Chaix, P. de Sepulveda, T. J. Kubiseski, N. Varin-Blank, and L. Velazquez Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells Blood, November 15, 2008; 112(10): 4039 - 4047. [Abstract] [Full Text] [PDF]

				I. S. Hitchcock, M. M. Chen, J. R. King, and K. Kaushansky YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation Blood, September 15, 2008; 112(6): 2222 - 2231. [Abstract] [Full Text] [PDF]

				S. Gery, S. Gueller, K. Chumakova, N. Kawamata, L. Liu, and H. P. Koeffler Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders Blood, November 1, 2007; 110(9): 3360 - 3364. [Abstract] [Full Text] [PDF]

				S. K. Frankel, G. P. Cosgrove, S.-I. Cha, C. D. Cool, M. W. Wynes, B. L. Edelman, K. K. Brown, and D. W. H. Riches TNF-{alpha} Sensitizes Normal and Fibrotic Human Lung Fibroblasts to Fas-Induced Apoptosis Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 293 - 304. [Abstract] [Full Text] [PDF]

				P. G. Heller, A. C. Glembotsky, M. J. Gandhi, C. L. Cummings, C. J. Pirola, R. F. Marta, L. I. Kornblihtt, J. G. Drachman, and F. C. Molinas Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation Blood, June 15, 2005; 105(12): 4664 - 4670. [Abstract] [Full Text] [PDF]

				J.-M. Paulus, N. Debili, F. Larbret, J. Levin, and W. Vainchenker Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors Blood, October 15, 2004; 104(8): 2291 - 2298. [Abstract] [Full Text] [PDF]